Growth Metrics

Omeros (OMER) Accumulated Depreciation & Amortization (2011 - 2026)

Omeros recorded quarterly Accumulated Depreciation & Amortization of $12.3 million in Q1 2026, up 1127.5% quarter-over-quarter from $1.0 million in Q4 2025, and up 8.05% year-over-year from $11.4 million in Q1 2025.

Omeros' Accumulated Depreciation & Amortization history runs 16 years deep, the most recent figure standing at $12.3 million for Q1 2026.

  • In Q1 2026, Accumulated Depreciation & Amortization rose 8.05% year-over-year to $12.3 million; the TTM figure through Mar 2026 stood at $12.3 million (up 8.05% YoY), while the FY2025 annual figure was $1.0 million, changed 0.0% from the prior year.
  • Accumulated Depreciation & Amortization came in at $12.3 million for Q1 2026 at Omeros, up from $1.0 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $12.3 million in Q1 2026 to a low of $1000.0 in Q4 2022.
  • A 5-year average of $7.1 million and a median of $9.5 million in 2023 frame the typical range for Accumulated Depreciation & Amortization.
  • Across the five-year window, Accumulated Depreciation & Amortization tumbled 99.93% in 2022 and surged 89900.0% in 2023, its largest moves.
  • Omeros' Accumulated Depreciation & Amortization stood at $1000.0 in 2022, then soared by 89900.0% to $900000.0 in 2023, then increased by 11.11% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then soared by 1127.5% to $12.3 million in 2026.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $12.3 million, $1.0 million, and $11.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12.28 Mn
Mar 31, 2026 12.28 Mn
Dec 31, 2025 1.00 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 11.80 Mn
Sep 30, 2025 11.80 Mn
Jun 30, 2025 11.55 Mn
Jun 30, 2025 11.55 Mn
Mar 31, 2025 11.36 Mn
Mar 31, 2025 11.36 Mn
Dec 31, 2024 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 10.77 Mn
Sep 30, 2024 10.77 Mn
Jun 30, 2024 10.54 Mn
Jun 30, 2024 10.54 Mn
Mar 31, 2024 10.45 Mn
Mar 31, 2024 10.45 Mn
Dec 31, 2023 900,000.00
Dec 31, 2023 900,000.00
Sep 30, 2023 200,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 9.84 Mn
Jun 30, 2023 9.84 Mn
Mar 31, 2023 9.51 Mn
Mar 31, 2023 9.51 Mn
Dec 31, 2022 1,000.00
Dec 31, 2022 1,000.00
Sep 30, 2022 800,000.00
Sep 30, 2022 800,000.00
Jun 30, 2022 9.44 Mn
Jun 30, 2022 9.44 Mn
Mar 31, 2022 9.31 Mn
Mar 31, 2022 9.31 Mn
Dec 31, 2021 1.40 Mn
Dec 31, 2021 1.40 Mn
Sep 30, 2021 8.71 Mn
Sep 30, 2021 8.71 Mn
Jun 30, 2021 8.39 Mn
Jun 30, 2021 8.39 Mn
Mar 31, 2021 8.04 Mn
Mar 31, 2021 8.04 Mn
Dec 31, 2020 7.65 Mn
Dec 31, 2020 7.65 Mn
Sep 30, 2020 7.25 Mn
Sep 30, 2020 7.25 Mn
Jun 30, 2020 6.85 Mn
Jun 30, 2020 6.85 Mn
Mar 31, 2020 6.44 Mn
Mar 31, 2020 6.44 Mn
Dec 31, 2019 6.04 Mn
Dec 31, 2019 6.04 Mn
Sep 30, 2019 5.51 Mn
Sep 30, 2019 5.51 Mn
Jun 30, 2019 5.07 Mn
Jun 30, 2019 5.07 Mn
Mar 31, 2019 377,000.00
Mar 31, 2019 377,000.00
Dec 31, 2018 962,000.00
Dec 31, 2018 962,000.00
Mar 31, 2018 223,000.00
Mar 31, 2018 223,000.00
Dec 31, 2017 551,000.00
Dec 31, 2017 551,000.00
Dec 31, 2016 300,000.00
Dec 31, 2016 300,000.00
Dec 31, 2015 209,000.00
Dec 31, 2015 209,000.00
Dec 31, 2014 317,000.00
Dec 31, 2014 317,000.00
Dec 31, 2013 302,000.00
Dec 31, 2013 302,000.00
Dec 31, 2012 1.79 Mn
Dec 31, 2012 1.79 Mn
Dec 31, 2011 2.48 Mn
Dec 31, 2011 2.48 Mn